Welcome to our dedicated news page for VHAI (Ticker: VHAI), a resource for investors and traders seeking the latest updates and insights on VHAI.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect VHAI's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of VHAI's position in the market.

Rhea-AI Summary
Vocodia Holdings Corp (VHAI) successfully closes its underwritten initial public offering, raising $5.95 million. The IPO consists of 1,400,000 Units, including common stock, Series A Warrants, and Series B Warrants. The Company also granted underwriters an option to purchase additional shares. The offering price per Unit was $4.2500, with gross proceeds of $5,558,764.75 received. The stock, along with the warrants, began trading on the BZX Exchange under ticker symbols 'VHAI,' 'VHAI+A,' and 'VHAI+B'. The net proceeds will be used for acquisitions, technology development, product expansion, sales, marketing, and general corporate purposes.
Rhea-AI Impact
Rhea-AI Sentiment
-- %


VHAI Rankings

VHAI Stock Data